The Norwegian Research Council granted BerGenBio, Lifandis and Smartfish – all Oslo Cancer Cluster member companies – funding through the Programme for User-Driven Research Based Innovation (BIA).
In total, the Research Council will grant a record amount of over 600 MNOK to 65 Norwegian companies, of which 9 are biotech companies.
BerGenBio, Lifandis and Smartfish will receive around 10 million NOK each over 4 years, depending on the outcome of the contract negotiations between the council and the companies. Funding from the BIA programme is a quality stamp since the companies compete in “open class” where all sectors are represented. The funding may also trigger interest from private investors. BerGenBio also received funding from BIA one year ago.
On the Research Council`s website you may more information and a list of all the companies that received funding now (in Norwegian).
October 14th 2015 is next application deadline for funding from the BIA-programme.